AONC
American Oncology Network Inc.
11.10$
+0.0%
vs. previous close
Closing price · As of: Aug 19, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | +0.4% | -2.9% | -94.1% | +1.0% | +1,931.2% | -5.0% | +12.7% | +2.1% | -8.3% | +19.1% | |
| – | -40.9% | -30.0% | +54,544.4% | -99.9% | -46.0% | +317,635.8% | -6.9% | +16.6% | -5.5% | -11.4% | +22.2% | |
| – | -50.0% | -20.5% | +11,545.6% | -100.0% | -48.6% | +2,526,954.8% | -44.7% | +162.6% | -54.9% | -42.5% | +223.4% | |
| – | -50.0% | -20.5% | +15,806.3% | -100.0% | -48.6% | +3,800,633.9% | -17.7% | +64.3% | -47.4% | -64.8% | +273.8% | |
| – | – | – | +105,200.7% | +8.0% | +0.1% | -0.1% | -8.0% | +2.8% | +11.2% | +2.5% | -1.8% | |
| – | – | – | – | -13.3% | +32.5% | -9.7% | +17.8% | -0.6% | +22.6% | -9.2% | +23.2% | |
| – | – | – | – | +2.2% | +2.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | -85.4% | +583.3% | +101.3% | +0.0% | +0.0% | |
| – | -10.5% | -11.8% | +1,714.4% | -92.3% | -46.2% | +3,258.5% | +0.8% | -0.8% | +3.0% | -9.6% | +6.3% | |
| – | -14.0% | +119.5% | +7,444.6% | -94.9% | +21.0% | +1,842.4% | +0.7% | +38.3% | -1.0% | -13.7% | +8.5% | |
| – | – | – | – | -98.4% | +33.3% | +3,776.5% | +103.3% | +0.5% | -21.0% | -1.0% | -1.3% | |
| – | -14.0% | +12,415.9% | +0.0% | -96.5% | +3,175.4% | -1.5% | +6.0% | +47.5% | +0.6% | -17.9% | +9.8% | |
| – | – | – | – | – | – | – | +0.3% | +0.3% | +9.1% | -0.7% | -0.6% | |
| – | +0.6% | +1.1% | -104.4% | – | – | -4,114.3% | – | – | – | -255.3% | – | |
| – | – | – | – | -176.1% | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -77.1% | +0.0% | -30.6% | +1.1% | +12.6% | +38.1% | +27.6% | +1.7% |
Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.